The use of stress echocardiography for prognostication in coronary artery disease: An overview

Current Opinion in Cardiology

Volumn 20, Issue 5, 2005, Pages 386-394

  Biagini, Elena ^a,b   Elhendy, Abdou ^a   Bax, Jeroen J ^c   Schinkel, Arend F L ^c   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Coronary artery disease; Prognosis; Stress echocardiography

Indexed keywords

ACUTE HEART INFARCTION; BLOOD VESSEL WALL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; HEART EJECTION FRACTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; STRESS ECHOCARDIOGRAPHY; SYSTOLIC BLOOD PRESSURE; VASCULAR SURGERY;

CORONARY ARTERIOSCLEROSIS; ECHOCARDIOGRAPHY, STRESS; HEART; HUMANS; PROGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 23944496627     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hco.0000175516.50181.c0     Document Type: Review

References (147)

1. Armstrong WF, Pellikka PA, Ryan T, et al. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 1998; 11:97-104.
2. Sicari R, Pasanisi E, Venneri L, et al. Stress echo results predict mortality: a large-scale multicenter prospective international study. J Am Coll Cardiol 2003; 41:589-595.
3. Pingitore A, Picano E, Varga A, et al. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups. J Am Coll Cardiol 1999; 34:1769-1777.
4. Poldermans D, Fioretti PM, Boersma E, et al. Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: a single-center experience. Circulation 1999; 99:757-762.
5. Arruda-Olson AM, Juracan EM, Mahoney DW, et al. Prognostic value of exercise echocardiography in 5,798 patients: is there a gender difference? J Am Coll Cardiol 2002; 39:625-631.
6. Biagini E, Elhendy A, Bax JJ, et al. Seven-year follow-up after dobutamine stress echocardiography: impact of gender on prognosis. J Am Coll Cardiol 2005; 45:93-97. This article demonstrates that although in patients with normal dobutamine stress echocardiography gender is independently associated with cardiac events, the outcome in patients with abnormal dobutamine stress echocardiography is related not to gender but rather to severity of left ventricular dysfunction and ischemia.
7. Marwick TH, Case C, Sawada S, et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol 2001; 37:754-760.
8. Chuah SC, Pellikka PA, Roger VL, et al. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation 1998; 97:1474-1480.
9. McCully RB, Roger VL, Mahoney DW, et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. J Am Coll Cardiol 1998; 31:144-149.
10. Elhendy A, Schinkel AF, Bax JJ, et al. Prognostic value of dobutamine stress echocardiography in patients with normal left ventricular systolic function. J Am Soc Echocardiogr 2004; 17:739-743. This study in 528 patients with normal baseline left ventricular systolic function who underwent high-dose dobutamine-atropine stress echocardiography shows that stress-induced wall-motion abnormalities are independently associated with increased risk of all-cause mortality and hard cardiac events.
11. Sozzi FB, Elhendy A, Roelandt JR, et al. Long-term prognosis after normal dobutamine stress echocardiography. Am J Cardiol 2003; 92:1267-1270.
12. Geleijnse ML. Cardiac outcome after normal stress echocardiography: a multicenter study in 6,799 patients. Circulation Suppl. S 2000; 102:1854.
13. Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309:331-336.
14. Volpi A, De Vita C, Franzosi MG, et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis: results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base. Circulation 1993; 88:416-429.
15. Tamaki N, Kawamoto M, Takahashi N, et al. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging. J Am Coll Cardiol 1993; 22:1621-1627.
16. Sicari R, Ripoli A, Picano E, et al. The prognostic value of myocardial viability recognized by low dose dipyridamole echocardiography in patients with chronic ischaemic left ventricular dysfunction. Eur Heart J 2001; 22:837-844.
17. Tibbits PA, Evaul JE, Goldstein RE, et al. Serial acquisition of data to predict one-year mortality rate after acute myocardial infarction. Am J Cardiol 1987; 60:451-455.
18. Picano E, Sicari R, Landi P, et al. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. Circulation 1998; 98:1078-1084.
19. Salustri A, Ciavatti M, Seccareccia F, Palamara A. Prediction of cardiac events after uncomplicated acute myocardial infarction by clinical variables and dobutamine stress test. J Am Coll Cardiol 1999; 34:435-440.
20. Previtali M, Fetiveau R, Lanzarini L, et al. Prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis. J Am Coll Cardiol 1998; 32:380-386.
21. Sicari R, Picano E, Landi P, et al. Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Cooperative (EDIC) Study. J Am Coll Cardiol 1997; 29: 254-260.
22. Desideri A, Candelpergher G, Zanco P, et al. G Ital Cardiol 1997; 27: 908-914. [Echocardiography or stress scintigraphy with dipyridamole for the stratification of risk after acute myocardial infarction?].
23. van Daele ME, McNeill AJ, Fioretti PM, et al. Prognostic value of dipyridamole sestamibi single-photon emission computed tomography and dipyridamole stress echocardiography for new cardiac events after an uncomplicated myocardial infarction. J Am Soc Echocardiogr 1994; 7:370-380.
24. Carlos ME, Smart SC, Wynsen JC, Sagar KB. Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation 1997; 95:1402-1410.
25. Chiarella F, Domenicucci S, Bellotti P, et al. Dipyridamole echocardiographic test performed 3 days after an acute myocardial infarction: feasibility, tolerability, safety and in-hospital prognostic value. Eur Heart J 1994; 15:842-850.
26. Picano E, Landi P, Bolognese L, et al. Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: a large-scale, multicenter trial. The EPIC Study Group. Am J Med 1993; 95:608-618.
27. Bigi R, Galati A, Curti G, et al. Prognostic value of residual ischaemia assessed by exercise electrocardiography and dobutamine stress echocardiography in low-risk patients following acute myocardial infarction. Eur Heart J 1997; 18:1873-1881.
28. Minardi G, Di Segni M, Manzara CC, et al. Diagnostic and prognostic value of dipyridamole and dobutamine stress echocardiography in patients with Q-wave acute myocardial infarction. Am J Cardiol 1997; 80: 847-851.
29. Wang CH, Cherng WJ, Hua CC, Hung MJ. Prognostic value of dobutamine echocardiography in patients after Q-wave or non-Q-wave acute myocardial infarction. Am J Cardiol 1998; 82:38-42.
30. Greco CA, Salustri A, Seccareccia F, et al. Prognostic value of dobutamine echocardiography early after uncomplicated acute myocardial infarction: a comparison with exercise electrocardiography. J Am Coll Cardiol 1997; 29:261-267.
31. Vanoverschelde JL, Gerber BL, D'Hondt AM, et al. Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization: role of low-dose dobutamine echocardiography and exercise-redistribution-reinjection thallium SPECT. Circulation 1995; 92:II37-II44.
32. Wijns W, Vatner SF, Camici PG. Hibernating myocardium. N Engl J Med 1998; 339:173-181.
33. Bax JJ, Poldermans D, Elhendy A, et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999; 34:163-169.
34. Meluzin J, Cerny J, Frelich M, et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this multicenter study. J Am Coll Cardiol 1998; 32:912-920.
35. Rizzello V, Poldermans D, Boersma E, et al. Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy: role of myocardial viability. Circulation 2004; 110:2383-2388. This study shows that substantial myocardial viability prevents ongoing left ventricular remodeling after revascularization and is associated with improvement of symptoms and favorable long-term prognosis.
36. Bax JJ, Poldermans D, Schinkel AF, et al. Perfusion and contractile reserve in chronic dysfunctional myocardium: relation to functional outcome after surgical revascularization. Circulation 2002; 106:114-118.
37. Williams MJ, Odabashian J, Lauer MS, et al. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996; 27:132-139.
38. Bax JJ, Schinkel AF, Boersma E, et al. Early versus delayed revascularization in patients with ischemic cardiomyopathy and substantial viability: impact on outcome. Circulation 2003; 108(Suppl 1):II39-II42.
39. Afridi I, Grayburn PA, Panza JA, et al. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 1998; 32: 921-926.
40. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol 1999; 33:1848-1854.
41. Chaudhry FA, Tauke JT, Alessandrini RS, et al. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 1999; 34:730-738.
42. Pagley PR, Beller GA, Watson DD, et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997; 96:793-800.
43. Pagano D, Lewis ME, Townend JN, et al. Coronary revascularisation for postischaemic heart failure: how myocardial viability affects survival. Heart 1999; 82:684-688.
44. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39:1151-1158.
45. Bax JJ, Schinkel AF, Boersma E, et al. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. Circulation 2004; 110:1118-1122. This study involving 79 consecutive patients indicates that extensive left ventricular remodeling prohibits improvement in left ventricular ejection fraction after revascularization and affects long-term prognosis negatively, despite the presence of viability.
46. Smart SC, Dionisopoulos PN, Knickelbine TA, et al. Dobutamine-atropine stress echocardiography for risk stratification in patients with chronic left ventricular dysfunction. J Am Coll Cardiol 1999; 33:512-521.
47. Sawada S, Bapat A, Vaz D, et al. Incremental value of myocardial viability for prediction of long-term prognosis in surgically revascularized patients with left ventricular dysfunction. J Am Coll Cardiol 2003; 42:2099-2105.
48. Lye M, Donnellan C. Heart disease in the elderly. Heart 2000; 84:560-566.
49. Wei JY. Age and the cardiovascular system. N Engl J Med 1992; 327: 1735-1739.
50. Beller GA. Are you ever too old to be risk stratified? J Am Coll Cardiol 1992; 19:1399-1401.
51. Arruda AM, Das MK, Roger VL, et al. Prognostic value of exercise echocardiography in 2,632 patients > or = 65 years of age. J Am Coll Cardiol 2001; 37:1036-1041.
52. Riley CP, Oberman A, Lampton TD, Hurst DC. Submaximal exercise testing in a random sample of an elderly population. Circulation 1970; 42:43-52.
53. Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. J Am Coll Cardiol 1997; 29:862-879.
54. Camerieri A, Picano E, Landi P, et al. Prognostic value of dipyridamole echocardiography early after myocardial infarction in elderly patients. Echo Persantine Italian Cooperative (EPIC) Study Group. J Am Coll Cardiol 1993; 22:1809-1815.
55. Bonou M, Benroubis A, Kranidis A, et al. Functional and prognostic significance of silent ischemia during dobutamine stress echocardiography in the elderly. Coron Artery Dis 2001; 12:499-506.
56. Anthopoulos LP, Bonou MS, Kardaras FG, et al. Stress echocardiography in elderly patients with coronary artery disease: applicability, safety and prognostic value of dobutamine and adenosine echocardiography in elderly patients. J Am Coll Cardiol 1996; 28:52-59.
57. Poldermans D, Fioretti PM, Boersma E, et al. Dobutamine-atropine stress echocardiography in elderly patients unable to perform an exercise test: hemodynamic characteristics, safety, and prognostic value. Arch Intern Med 1994; 154:2681-2686.
58. Ferrara N, Leosco D, Abete P, et al. Dipyridamole echocardiography as a useful and safe test in the assessment of coronary artery disease in the elderly. J Am Geriatr Soc 1991; 39:993-999.
59. Biagini E, Thomas JL, Braus PA, et al. Long-term prediction of mortality in the elderly by dobutamine stress echocardiography. J Gerontol 2005 (in press).
60. Thomas JL, Braus PA. Coronary artery disease in women: a historical perspective. Arch Intern Med 1998; 158:333-337.
61. Mosca L, Manson JE, Sutherland SE, et al. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. Circulation 1997; 96:2468-2482.
62. Shaw LJ, Miller DD, Romeis JC, et al. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 1994; 120:559-566.
63. Douglas PS. Is noninvasive testing for coronary artery disease accurate? Circulation 1997; 95:299-302.
64. Cortigiani L, Dodi C, Paolini EA, et al. Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease. J Am Coll Cardiol 1998; 32:1975-1981.
65. Elhendy A, Geleijnse ML, van Domburg RT, et al. Gender differences in the accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery disease. Am J Cardiol 1997; 80:1414-1418.
66. Rollan MJ, San Roman JA, Vilacosta I, et al. Dobutamine stress echocardiography in the diagnosis of coronary artery disease in women with chest pain: comparison with different noninvasive tests. Clin Cardiol 2002; 25: 559-564.
67. Takeuchi M, Sonoda S, Miura Y, Kuroiwa A. Comparative diagnostic value of dobutamine stress echocardiography and stress thallium-201 single-photon- emission computed tomography for detecting coronary artery disease in women. Coron Artery Dis 1996; 7:831-835.
68. Elhendy A, van Domburg RT, Bax JJ, et al. Noninvasive diagnosis of coronary artery stenosis in women with limited exercise capacity: comparison of dobutamine stress echocardiography and 99mTc sestamibi single-photon emission CT. Chest 1998; 114:1097-1104.
69. Masini M, Picano E, Lattanzi F, et al. High dose dipyridamole- echocardiography test in women: correlation with exercise-electrocardiography test and coronary arteriography. J Am Coll Cardiol 1988; 12:682-685.
70. Sawada SG, Ryan T, Fineberg NS, et al. Exercise echocardiographic detection of coronary artery disease in women. J Am Coll Cardiol 1989; 14: 1440-1447.
71. Marwick TH, Anderson T, Williams MJ, et al. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol 1995; 26:335-341.
72. Ho YL, Wu CC, Huang PJ, et al. Assessment of coronary artery disease in women by dobutamine stress echocardiography: comparison with stress thallium-201 single-photon emission computed tomography and exercise electrocardiography. Am Heart J 1998; 135:655-662.
73. Dionisopoulos PN, Collins JD, Smart SC, et al. The value of dobutamine stress echocardiography for the detection of coronary artery disease in women. J Am Soc Echocardiogr 1997; 10:811-817.
74. Davar Jl, Brull DJ, Bulugahipitiya S, et al. Prognostic value of negative dobutamine stress echo in women with intermediate probability of coronary artery disease. Am J Cardiol 1999; 83:100-102.
75. Heupler S, Mehta R, Lobo A, et al. Prognostic implications of exercise echocardiography in women with known or suspected coronary artery disease. J Am Coll Cardiol 1997; 30:414-420.
76. Cortigiani L, Gigli G, Vallebona A, et al. The stress echo prognostic gender gap. Eur J Echocardiogr 2001; 2:132-138.
77. Dodi C, Cortigiani L, Masini M, et al. The incremental prognostic value of pharmacological stress echo over exercise electrocardiography in women with chest pain of unknown origin. Eur Heart J 2001; 22:145-152.
78. Hachamovitch R, Berman DS, Kiat H, et al. Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Cardiol 1996; 28:34-44.
79. Amanullah AM, Berman DS, Erel J, et al. Incremental prognostic value of adenosine myocardial perfusion single-photon emission computed tomography in women with suspected coronary artery disease. Am J Cardiol 1998; 82:725-730.
80. Pancholy SB, Fattah AA, Kamal AM, et al. Independent and incremental prognostic value of exercise thallium single-photon emission computed tomographic imaging in women. J Nucl Cardiol 1995; 2:110-116.
81. Elhendy A, Schinkel AF, van Domburg RT, et al. Prediction of all-cause mortality in women with known or suspected coronary artery disease by stress technetium-99m tetrofosmin myocardial perfusion imaging. Am J Cardiol 2004; 93:450-452.
82. Biagini E, Halimi S, Hammoud T, et al. Comparison of all-cause mortality in women with known or suspected coronary artery disease referred for dobutamine stress echocardiography with normal vs. abnormal test results. Am J Cardiol 2005 (in press).
83. Mak KH, Moliterno DJ, Granger CB, et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1997; 30: 171-179.
84. Vanzetto G, Halimi S, Hammoud T, et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients: prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care 1999; 22:19-26.
85. Felsher J, Meissner MD, Hakki AH, et al. Exercise thallium imaging in patients with diabetes mellitus: prognostic implications. Arch Intern Med 1987; 147:313-317.
86. Kang X, Berman DS, Lewin HC, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999; 138:1025-1032.
87. Elhendy A, Arruda AM, Mahoney DW, Pellikka PA. Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol 2001; 37: 1551-1557.
88. Marwick TH, Case C, Sawada S, et al. Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care 2002; 25:1042-1048.
89. Kamalesh M, Matorin R, Sawada S. Prognostic value of a negative stress echocardiographic study in diabetic patients. Am Heart J 2002; 143:163-168.
90. Sozzi FB, Elhendy A, Roelandt JR, et al. Prognostic value of dobutamine stress echocardiography in patients with diabetes. Diabetes Care 2003; 26:1074-1078.
91. Gaddi O, Tortorella G, Picano E, et al. Diagnostic and prognostic value of vasodilator stress echocardiography in asymptomatic Type 2 diabetic patients with positive exercise thallium scintigraphy: a pilot study. Diabet Med 1999; 16:762-766.
92. Bigi R, Desideri A, Cortigiani L, et al. Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease. Diabetes Care 2001; 24:1596-1601.
93. Maltagliati A, Berti M, Muratori M, et al. Exercise echocardiography versus exercise electrocardiography in the diagnosis of coronary artery disease in hypertension. Am J Hypertens 2000; 13:796-801.
94. Fragasso G, Lu C, Dabrowski P, et al. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test. J Am Coll Cardiol 1999; 34:441-447.
95. Astarita C, Palinkas A, Nicolai E, et al. Dipyridamole-atropine stress echocardiography versus exercise SPECT scintigraphy for detection of coronary artery disease in hypertensives with positive exercise test. J Hypertens 2001; 19:495-502.
96. Harrison DG, Marcus ML, Dellsperger KC, et al. Pathophysiology of myocardial perfusion in hypertension. Circulation 1991; 83:11114-11118.
97. Elhendy A, Geleijnse ML, van Domburg RT, et al. Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy. Eur J Nucl Med 1998; 25:69-78.
98. Elhendy A, Modesto KM, Mahoney DW, et al. Prediction of mortality in patients with left ventricular hypertrophy by clinical, exercise stress, and echocardiographic data. J Am Coll Cardiol 2003; 41:129-135.
99. Marwick TH, Case C, Sawada S, et al. Prediction of outcomes in hypertensive patients with suspected coronary disease. Hypertension 2002; 39:1113-1118.
100. Cortigiani L, Coletta C, Bigi R, et al. Clinical, exercise electrocardiographic, and pharmacologic stress echocardiographic findings for risk stratification of hypertensive patients with chest pain. Am J Cardiol 2003; 91:941-945.
101. Mondillo S, Agricola E, Ammaturo T, et al. Prognostic value of dipyridamole stress echocardiography in hypertensive patients with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities. Can J Cardiol 2001; 17:571-577.
102. Cortigiani L, Paolini EA, Nannini E. Dipyridamole stress echocardiography for risk stratification in hypertensive patients with chest pain. Circulation 1998; 98:2855-2859.
103. Sozzi FB, Elhendy A, Rizzello V, et al. Prognostic value of dobutamine stress echocardiography in patients with systemic hypertension and known or suspected coronary artery disease. Am J Cardiol 2004; 94:733-739. This study shows that dobutamine stress echocardiography provides incremental data for the prediction of mortality rate and hard cardiac events in patients who have hypertension, after adjustment for clinical data and left ventricular mass index.
104. Cooksey JD, Parker BM, Bahl OP. The diagnostic contribution of exercise testing in left bundle branch block. Am Heart J 1974; 88:482-486.
105. Ibrahim NS, Abboud G, Selvester RS, et al. Detecting exercise-induced ischemia in left bundle branch block using the electrocardiogram. Am J Cardiol 1998; 82:832-835.
106. Orzan F, Garcia E, Mathur VS, Hall RJ. Is the treadmill exercise test useful for evaluating coronary artery disease in patients with complete left bundle branch block? Am J Cardiol 1978; 42:36-40.
107. Watanabe T, Harumi K, Akutsu Y, et al. Relation between exercise-induced myocardial ischemia as assessed by nitrogen-13 ammonia positron emission tomography and QT interval behavior in patients with right bundle branch block. Am J Cardiol 1998; 81:816-821.
108. Yen RS, Miranda C, Froelicher VF. Diagnostic and prognostic accuracy of the exercise electrocardiogram in patients with preexisting right bundle branch block. Am Heart J 1994; 127:1521-1525.
109. Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997; 30:260-311.
110. Bonow RO. Prognostic assessment in coronary artery disease: role of radionuclide angiography. J Nucl Cardiol 1994; 1:280-291.
111. Miller TD, Christian TF, Taliercio CP, et al. Severe exercise-induced ischemia does not identify high risk patients with normal left ventricular function and one- or two-vessel coronary artery disease. J Am Coll Cardiol 1994; 23: 219-224.
112. Colon PJ 3rd, Mobarek SK, Milani RV, et al. Prognostic value of stress echocardiography in the evaluation of atypical chest pain patients without known coronary artery disease. Am J Cardiol 1998; 81:545-551.
113. Demir H, Erbay G, Kir KM, et al. Clinical validation of technetium-99m MIBI-gated single-photon emission computed tomography (SPECT) for avoiding false positive results in patients with left bundle-branch block: comparison with stress-rest nongated SPECT. Clin Cardiol 2003; 26: 182-187.
114. Alexanderson E, Mannting F, Gomez-Martin D, et al. Technetium-99m- sestamibi SPECT myocardial perfusion imaging in patients with complete left bundle branch block. Arch Med Res 2004; 35:150-156. This article demonstrates that Tc-99m-MIBI SPECT imaging has moderate sensitivity and specificity for left anterior descending coronary artery disease in patients with left bundle branch block. Absence of apical defect is specific for excluding LAD disease. Reversible changes in anteroseptal wall should be considered as an indicator of ischemia in this territory.
115. Skalidis El, Kochiadakis GE, Koukouraki SI, et al. Myocardial perfusion in patients with permanent ventricular pacing and normal coronary arteries. J Am Coll Cardiol 2001; 37:124-129.
116. Peteiro J, Monserrat L, Martinez D, Castro-Beiras A. Accuracy of exercise echocardiography to detect coronary artery disease in left bundle branch block unassociated with either acute or healed myocardial infarction. Am J Cardiol 2000; 85:890-893.
117. Yanik A, Yetkin E, Senen K, et al. Value of dobutamine stress echocardiography for diagnosis of coronary artery disease in patients with left bundle branch blockage. Coron Artery Dis 2000; 11:545-548.
118. Picano E, Alaimo A, Chubuchny V, et al. Noninvasive pacemaker stress echocardiography for diagnosis of coronary artery disease: a multicenter study. J Am Coll Cardiol 2002; 40:1305-1310.
119. Vigna C, Stanislao M, De Rito V, et al. Dipyridamole stress echocardiography vs dipyridamole sestamibi scintigraphy for diagnosing coronary artery disease in left bundle-branch block. Chest 2001; 120:1534-1539.
120. Geleijnse ML, Vigna C, Kasprzak JD, et al. Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block: a multicentre study. Eur Heart J 2000; 21:1666-1673.
121. Cortigiani L, Picano E, Vigna C, et al. Prognostic value of pharmacologic stress echocardiography in patients with left bundle branch block. Am J Med 2001; 110:361-369.
122. Cortigiani L, Bigi R, Gigli G, et al. Prognostic implications of intraventricular conduction defects in patients undergoing stress echocardiography for suspected coronary artery disease. Am J Med 2003; 115:12-18.
123. Biagini E, Schinkel AF, Rizzello V, et al. Prognostic stratification of patients with right bundle branch block using dobutamine stress echocardiography. Am J Cardiol 2004; 94:954-957. This study evaluated the role of dobutamine stress echocardiography for the prognostic stratification of 176 patients with right bundle branch block who were followed up for 4 years. The presence of an abnormal dobutamine stress echocardiography was the strongest predictor of cardiac events and provided incremental prognostic information to clinical and stress test data.
124. Cortigiani L, Bigi R, Gigli G, et al. Prediction of mortality in patients with right bundle branch block referred for pharmacologie stress echocardiography. Am J Cardiol 2003; 92:1429-1433.
125. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990; 72: 153-184.
126. Biagini E, Layug EL, Reilly LM, et al. Long-term prognostic value of pacing stress echocardiography. Eur J Echocardiogr 2004; 5(Suppl 1):S246.
127. Boersma E, Poldermans D, Bax JJ, et al. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 2001; 285:1865-1873.
128. L'Italien GJ, Cambria RP, Cutler BS, et al. Comparative early and late cardiac morbidity among patients requiring different vascular surgery procedures. J Vasc Surg 1995; 21:935-944.
129. Krupski WC, Layug EL, Reilly LM, et al. Comparison of cardiac morbidity rates between aortic and infrainguinal operations: two-year follow-up. Study of Perioperative Ischemia Research Group. J Vasc Surg 1993; 18:609-615; discussion 615-617.
130. Sicari R, Ripoli A, Picano E, et al. Perioperative prognostic value of dipyridamole echocardiography in vascular surgery: a large-scale multicenter study in 509 patients. EPIC (Echo Persantine International Cooperative) Study Group. Circulation 1999; 100:11269-11274.
131. Tischler MD, Lee TH, Hirsch AT, et al. Prediction of major cardiac events after peripheral vascular surgery using dipyridamole echocardiography. Am J Cardiol 1991; 68:593-597.
132. Shaw LJ, Eagle KA, Gersh BJ, Miller DD. Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol 1996; 27:787-798.
133. Zamorano J, Duque A, Baquero M, et al. Rev Esp Cardiol 2002; 55: 121-126. [Stress echocardiography in the pre-operative evaluation of patients undergoing major vascular surgery: are results comparable with dipyridamole versus dobutamine stress echo?]
134. Sicari R, Picano E, Lusa AM, et al. The value of dipyridamole echocardiography in risk stratification before vascular surgery: a multicenter study. The EPIC (Echo Persantine International Study) Group-Subproject: Risk Stratification Before Major Vascular Surgery. Eur Heart J 1995; 16:842-847.
135. Rossi E, Citterio F, Vescio MF, et al. Risk stratification of patients undergoing peripheral vascular revascularization by combined resting and dipyridamole echocardiography. Am J Cardiol 1998; 82:306-310.
136. Pasquet A, D'Hondt AM, Verhelst R, et al. Comparison of dipyridamole stress echocardiography and perfusion scintigraphy for cardiac risk stratification in vascular surgery patients. Am J Cardiol 1998; 82: 1468-1474.
137. Lane RT, Sawada SG, Segar DS, et al. Dobutamine stress echocardiography for assessment of cardiac risk before noncardiac surgery. Am J Cardiol 1991; 68:976-977.
138. Davila-Roman VG, Waggoner AD, Sicard GA, et al. Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease. J Am Coll Cardiol 1993; 21:957-963.
139. Lalka SG, Sawada SG, Dalsing MC, et al. Dobutamine stress echocardiography as a predictor of cardiac events associated with aortic surgery. J Vasc Surg 1992; 15:831-840; discussion 841-2.
140. Eichelberger JP, Schwarz KQ, Black ER, et al. Predictive value of dobutamine echocardiography just before noncardiac vascular surgery. Am J Cardiol 1993; 72:602-607.
141. Poldermans D, Fioretti PM, Forster T, et al. Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation 1993; 87:1506-1512.
142. Poldermans D, Arnese M, Fioretti PM, et al. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am Coll Cardiol 1995; 26:648-653.
143. Kertai MD, Boersma E, Bax JJ, et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 2003; 89: 1327-1334.
144. Bountioukos M, Elhendy A, van Domburg RT, et al. Prognostic value of dobutamine stress echocardiography in patients with previous coronary revascularisation. Heart 2004; 90:1031-1035.
145. Arruda AM, McCully RB, Oh JK, et al. Prognostic value of exercise echocardiography in patients after coronary artery bypass surgery. Am J Cardiol 2001; 87:1069-1073.
146. Dagianti A, Rosanio S, Penco M, et al. Clinical and prognostic usefulness of supine bicycle exercise echocardiography in the functional evaluation of patients undergoing elective percutaneous transluminal coronary angioplasty. Circulation 1997; 95:1176-1184.
147. Pirelli S, Massa D, Faletra F, et al. Exercise electrocardiography versus dipyridamole echocardiography testing in coronary angioplasty: early functional evaluation and prediction of angina recurrence. Circulation 1991; 83:11138-11142.